BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21984395)

  • 1. Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival.
    Giatromanolaki A; Sivridis E; Bechrakis NE; Willerding G; St Charitoudis G; Foerster MH; Gatter KC; Harris AL; Koukourakis MI
    Clin Exp Metastasis; 2012 Jan; 29(1):11-7. PubMed ID: 21984395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation.
    Giatromanolaki A; Koukourakis MI; Pezzella F; Sivridis E; Turley H; Harris AL; Gatter KC
    Hematol Oncol; 2008 Dec; 26(4):219-24. PubMed ID: 18461646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Chlouverakis G; Vourvouhaki E; Turley H; Harris AL; Gatter KC
    Eur J Clin Invest; 2007 Nov; 37(11):878-86. PubMed ID: 17883421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin.
    Giatromanolaki A; Sivridis E; Kouskoukis C; Gatter KC; Harris AL; Koukourakis MI
    Melanoma Res; 2003 Oct; 13(5):493-501. PubMed ID: 14512791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia and activated VEGF/receptor pathway in multiple myeloma.
    Giatromanolaki A; Bai M; Margaritis D; Bourantas KL; Koukourakis MI; Sivridis E; Gatter KC
    Anticancer Res; 2010 Jul; 30(7):2831-6. PubMed ID: 20683019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins.
    Giatromanolaki A; Koukourakis MI; Pezzella F; Sivridis E; Turley H; Harris AL; Gatter KC
    Leuk Lymphoma; 2008 Nov; 49(11):2181-6. PubMed ID: 19021062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.
    Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1422-8. PubMed ID: 11381041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
    Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Simopoulos C; Turley H; Talks K; Gatter KC; Harris AL
    Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1192-202. PubMed ID: 12128120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated KDR expression in endometrial cancer cells relates to HIF1alpha/VEGF pathway and unfavourable prognosis.
    Giatromanolaki A; Koukourakis MI; Turley H; Sivridis E; Harris AL; Gatter KC;
    Mod Pathol; 2006 May; 19(5):701-7. PubMed ID: 16557278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis.
    Giatromanolaki A; Sivridis E; Gatter KC; Turley H; Harris AL; Koukourakis MI;
    Gynecol Oncol; 2006 Dec; 103(3):912-8. PubMed ID: 16837029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth.
    Boyd SR; Tan DS; de Souza L; Neale MH; Myatt NE; Alexander RA; Robb M; Hungerford JL; Cree IA
    Br J Ophthalmol; 2002 Apr; 86(4):440-7. PubMed ID: 11914215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
    Giatromanolaki A; Sivridis E; Maltezos E; Papazoglou D; Simopoulos C; Gatter KC; Harris AL; Koukourakis MI
    J Clin Pathol; 2003 Mar; 56(3):209-13. PubMed ID: 12610101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer.
    Koukourakis MI; Giatromanolaki A; Simopoulos C; Polychronidis A; Sivridis E
    Clin Exp Metastasis; 2005; 22(1):25-30. PubMed ID: 16132575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
    Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
    Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased HIF-1α expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma.
    Mouriaux F; Sanschagrin F; Diorio C; Landreville S; Comoz F; Petit E; Bernaudin M; Rousseau AP; Bergeron D; Morcos M
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1277-83. PubMed ID: 24481264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of vascular endothelial growth factor in uveal melanoma is independent of 6p21-region copy number.
    Abdel-Rahman MH; Craig EL; Davidorf FH; Eng C
    Clin Cancer Res; 2005 Jan; 11(1):73-8. PubMed ID: 15671530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factor-A, matrix metalloproteinase-9, and extravascular matrix patterns and their correlations with clinicopathologic parameters in posterior uveal melanomas.
    Sahin A; Kiratli H; Soylemezoglu F; Tezel GG; Bilgic S; Saracbasi O
    Jpn J Ophthalmol; 2007; 51(5):325-331. PubMed ID: 17926107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1α and HIF2α in tumor-associated fibroblasts and human breast cancer cells.
    Chiavarina B; Martinez-Outschoorn UE; Whitaker-Menezes D; Howell A; Tanowitz HB; Pestell RG; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Sep; 11(17):3280-9. PubMed ID: 22894905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary tumor transforming gene (PTTG) stimulates thyroid cell proliferation via a vascular endothelial growth factor/kinase insert domain receptor/inhibitor of DNA binding-3 autocrine pathway.
    Kim DS; Franklyn JA; Boelaert K; Eggo MC; Watkinson JC; McCabe CJ
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4603-11. PubMed ID: 16926250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.